(1)
The annual cash bonus reflects the target cash bonus that the executive would have been entitled to receive under our 2017 Annual Incentive Bonus program, without pro-ration since the assumed date of termination is also the last day of the fiscal year.
(2)
The value of the restricted shares, performance-based shares, and stock options that would be accelerated upon a termination of employment is based on the closing price of our common stock on December 31, 2020, which was $196.34 per share.
(3)
Timothy Robinson ceased employment with the company as of March 31, 2020 and Joseph Kelleman ceased employment with the company as of July 31, 2020. Robinson’s actual severance payout was $427,450 plus a $299,215 annual cash bonus payout. Kelleman’s actual severance payout was $75,000 which was paid at retirement as a recognition bonus.
(4)
James Maloney’s potential payout is prorated based on his hire date of July 20, 2020.
CEO Pay Ratio
As required by Section 953(b) of the Dodd-Frank Wall Street Reform and Consumer Protection Act, and Item 402(u) of Regulation S-K, we are providing the following information about the relationship of the median of the annual total compensation of our employees and the annual total compensation of Mr. Daniel Chard, our CEO. For FY 2020, the annual total compensation of our CEO was $5,548,874 (base salary and incentive pay) and the annual total compensation of the median employee of our company (other than our CEO) was $60,848. As a result, the ratio between our CEO’s annual total compensation and the median of the annual total compensation of our employees (other than our CEO) was 91 to 1.
We identified the median total compensation of our employees by examining the 2020 total compensation for all individuals, excluding our CEO, who were employed by us on December 31, 2020, the last day of our payroll year. We included all employees, whether employed on a full-time, or part-time basis. For our newly hired permanent full-time or part-time employees that were employed for less than the full year, we annualized their 2020 total compensation. Employees of our Hong Kong and Singapore subsidiaries were excluded from this calculation, given that the employee population of these countries represents less than 5% of our total employee base.
In determining the median employee, we considered the total cash compensation for each active employee as of December 31, 2020, including regular pay, overtime pay, shift pay, regular exception pay (holiday, paid time off or PTO, jury, short-term disability, bereavement etc.), production and other incentives such as employee cash referral awards, bonuses paid (signing and discretionary), 2019 performance bonuses paid in 2020, stock dividends, imputed value of company-provided group term life insurance, and company contributions to employee 401(k) plans.
DIRECTOR COMPENSATION
We use cash and stock-based compensation to attract and retain qualified individuals to serve on our Board. The non-employee directors of Medifast receive an annual restricted stock grant for their service on the Board. In the fiscal year ended December 31, 2020, directors (other than Mr. Xian) were given the option to receive either 1,083 restricted shares and a quarterly cash retainer of $12,500 (for the Lead Director, an additional $5,000 quarterly cash retainer; and for the former non-executive Chairman of the Board, an additional $22,500 quarterly cash retainer), or to receive all compensation in the form of restricted shares with the grant date 20-day average share price used to determine the total number of shares granted, at their election.
Each of our non-employee directors other than Messrs. Sassano, MacDonald, and Xian and Ms. Hallquist elected to receive all of their compensation in the form of restricted shares. The restricted shares were granted at the June 2020 meeting of the Board and vest on June 30, 2021. Mr. Xian is a resident of China and, as such, did not receive restricted shares under our director compensation program. Instead, fees to Mr. Xian are paid in cash and cash-settled deferred share units. Each non-employee director also received between $1,250 and $5,000 for attending a quarterly committee meeting (depending on the committee and the position held), which he or she could also elect to receive in the form of shares.